Companies /Healthcare

IQVIA Holdings Inc

NYSE: IQV Diagnostics & Research
$262.01
▲ $1.33 (+0.51%) today
Markets closed · 5:33am ET

24/7 Wall St. View

IQV at a Glance

Valuation
Market cap
$43.1B
P/E ratio
32.5
Profitability
Revenue (TTM)
$17.0B
Profit margin
8.1%
EPS (TTM)
$8.05
Price
52-week range
$155 – $277
24/7 target
$311.97
Street target
$295.05
Earnings
Next report
Oct 27, 2026

Headquartered in Durham, NC Fiscal year ends December NYSE: IQV iqvia.com

About IQVIA

IQVIA Holdings Inc. (NYSE: IQV) is a global provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. The company operates through two segments: Commercial Solutions, which provides analytics, consulting, patient solutions, commercial engagement services, and AI-powered solutions to help biopharmaceutical companies commercialize products; and Research & Development Solutions, which offers clinical trial management, contract research, and related services to support drug development. IQVIA's offerings are powered by its Connected Intelligence platform, which combines large-scale health data assets, Healthcare-grade AI, advanced analytics, and domain expertise. The company employs approximately 94,000 people across more than 100 countries, serving biotech, medical device, pharmaceutical companies, medical researchers, government agencies, and payers. IQVIA maintains a significant contracted R&D backlog and emphasizes responsible AI deployment with privacy-enhancing technologies and regulatory compliance safeguards. Updated

IQV Coverage

Frequently Asked Questions

What does IQVIA do?

IQVIA Holdings Inc. (NYSE: IQV) is a global provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries.

What is the IQV stock price target?

24/7 Wall St.'s 12-month price target for IQV is $311.97, rated Buy. The Wall Street consensus target is $295.05. IQV price prediction →